A strict new vaccine approval process in the U.S. could dramatically slow things down for biopharma and the public, experts ...

Explore eight major immunology and inflammation (I&I) partnerships in 2025, from early-stage research to late-stage licensing ...

Take a look back into biotech in 2025 as the year is closing - from GLP-1s to radiopharmaceuticals and neuroplastogens.

Discover top biotech companies for 2026, featuring emerging stars and leaders set for major clinical and regulatory ...

Do you know someone whose competitive streak makes them ace board games? Does this person also geek out about the wonders of the immune system? The Viral board game might be the ideal biotechnology ...

BIO-Europe Startup Spotlight returns to Lisbon in March 2026, showcasing Europe’s top early-stage biotech pitches to industry ...

Ghent is boosting its biopharma hub with cutting-edge infrastructure, world-class research, and a thriving life sciences ...

An end-of-the-year slowdown has not been witnessed by the biopharma industry yet, and certainly not in the biotech deals ...

Did you know that chronic obstructive pulmonary disease (COPD) is actually the fourth leading cause of death worldwide? According to the World Health Organization (WHO), the lung disease, which ...

Discover what the next wave of AI-assisted drug discovery looks like and how it can help biotech - the AI and physics combo.

The companies Cogent Biosciences, Braveheart Bio, and AAVantgarde bagged the biggest biotech funding rounds overall in November 2025.

While non-exhaustive, this list offers an overview of the year’s biotech events taking place around the world, aimed at partnering and connecting with decision makers in biopharma. If there is a ...